Why peptides are a different kind of purchase
Collagen peptides, bioactive peptides, and peptide-based formulations have become some of the most in-demand ingredients in the wellness trade. Consumer interest is real and growing fast. But the financial mechanics of sourcing them are unlike almost anything else in the supplement category — and they catch many brands off guard the first time.
The difference isn't the payment structure itself. Most contract manufacturers (CMOs) require a deposit before production starts, regardless of what you're making. What's different with peptides is the combination of how much capital is at stake and how long it's tied up before you see any return.
A standard supplement order might require $8,000–$15,000 upfront for a few weeks. A peptide order often requires $20,000–$40,000 upfront — and that capital can be locked in for three to four months before it converts to revenue. That's a fundamentally different working capital challenge, and it requires planning in a way that most supplement categories simply don't.
What a peptide order actually costs — and when
Minimum order quantities
Most wellness brands source peptide products as finished goods from a CMO rather than buying raw ingredients directly. At this level, MOQs are quoted in finished units — typically 1,000 to 3,000 units per SKU for standard formulations. Custom blends or novel peptide combinations may require 3,000–5,000 units to justify a production run.
In dollar terms, that translates to $20,000–$80,000 per order depending on formulation complexity, peptide grade, and packaging. This is the first significant difference from most supplement categories: the floor for a viable order is high.
Payment timing
CMOs typically require a deposit at order placement — often 50% — with the balance due before goods ship. This is standard practice across manufacturing. What makes it meaningful for peptide brands is the math: on a $50,000 order, you need $25,000 available the day you place the order, and another $25,000 weeks later, before a single unit has shipped.
If your payment terms with retail or DTC customers are Net 30 or Net 60, the cash out before revenue in is entirely on your balance sheet. For a growing brand managing multiple SKUs, this compounds quickly.
Lead times and the full cash cycle
Production lead times are where the peptide sourcing cycle becomes genuinely long. US-based CMOs typically turn orders in 4–8 weeks from confirmation. Chinese manufacturers — which dominate global peptide supply and offer prices 30–50% lower — typically require 10–14 weeks for finished goods, with most brands choosing sea freight to control costs.
Add customs clearance, domestic freight, and the time to sell through and collect from customers, and your total cash-to-cash cycle on a peptide order is often 3–4 months. For brands with Net 30 or Net 60 retail terms, it can stretch longer. That's a meaningful commitment — and it repeats with every reorder as the brand scales.
An example: A wellness brand orders 2,000 units of a marine collagen peptide formulation for $48,000 from a Chinese CMO. They pay $24,000 at order placement, then $24,000 six weeks later before shipment. Sea freight and customs takes another four weeks. By the time inventory is in their warehouse, they're ten weeks and $48,000 deep — and the first wholesale revenue won't arrive for another 30–60 days after launch. The total gap from first payment to first revenue: close to four months.
US vs. Chinese manufacturers: cost, lead time, and what to ask for
Both US-based and Chinese manufacturers supply a significant share of the global peptide market, and choosing between them is a legitimate strategic decision — not a quality call.
Chinese manufacturers, particularly those based in Shaanxi province (the Xi'an hub), produce the majority of the world's collagen peptide supply and a growing share of bioactive peptide formulations. Pricing is typically 30–50% lower than US equivalents, and many of the largest Western wellness brands source from this region. Lead times are longer (10–14 weeks to your warehouse), and documentation quality varies significantly between suppliers — which is exactly why vetting matters more than geography.
US-based CMOs (including companies like Vitaquest and Makers Nutrition) offer shorter lead times (4–8 weeks), simpler customs logistics, and easier communication. They cost more, but for brands prioritizing speed to market or navigating complex formulations, the premium can be worth it.
Neither option is inherently better. What matters is understanding the trade-offs before you commit to an order — especially the cash flow implications of the different lead times.
Choosing a manufacturer: what to verify
| Criterion | Why It Matters | What to Ask For |
|---|---|---|
| GMP certification | Ensures consistent quality and is required for many international markets | Current GMP certificate (EU or US FDA-registered facility) |
| Certificate of Analysis (CoA) | Third-party verification of purity, potency, and contaminants | CoA from an accredited external lab for each batch — not self-issued |
| Source traceability | Required for labeling, allergen declarations, and certifications | Full traceability documentation to raw material source (bovine, marine, etc.) |
| Heavy metals testing | Peptides can accumulate heavy metals depending on source material | ICP-MS testing results for lead, arsenic, mercury, and cadmium |
| Pilot quantities | Your first order with a new supplier is a trial — flexibility matters | Whether they offer a sample or smaller pilot run before full MOQ commitment |
| Geography and lead time | US CMOs offer shorter lead times (4–8 weeks); Chinese manufacturers offer lower cost (30–50% cheaper) with longer lead times (10–14 weeks) | Production schedule, freight timeline, and whether sea or air freight is quoted |
| Payment term history | Upfront payment requirements ease as the relationship develops | What payment terms become available after 2–3 completed orders |
Managing the cash-flow gap
The working capital challenge in peptide sourcing is structural — it's built into the economics of the category. Planning for it before you place an order is dramatically easier than managing it after.
Map your full cash cycle before you commit
Start with when you need inventory on hand (your launch or restock date), then work backwards through freight and customs, production lead time, and the deposit schedule. That gives you two key dates: when cash goes out, and when it starts coming back. The gap between them is your financing need.
For a wellness brand with Net 30 retail terms, the cash gap on a $50,000 peptide order placed with a Chinese CMO can easily run 120–150 days from first payment to revenue recovery. That's a meaningful portion of working capital tied up in a single order.
Trade financing fits the peptide cycle well
Trade finance facilities — where a lender pays your manufacturer directly and you repay on a fixed schedule after goods arrive — are well-suited to this pattern. The key advantages for peptide brands specifically:
- Vendor payment on your manufacturer's terms. Your CMO gets paid when they need it — at deposit and before shipment — even before your inventory has shipped. This is exactly the payment structure peptide manufacturers require, and it keeps production moving without you depleting working capital reserves.
- Repayment aligned to your revenue cycle. Net 30, 60, or 90-day repayment terms mean you can time your repayment to coincide with when wholesale or DTC revenue from that order is arriving — rather than funding the entire gap from your own cash.
- Capital stays available for growth. Rather than tying $40,000–$80,000 in a single inventory order for months at a time, you preserve working capital for marketing, new product development, and other opportunities that arise while your order is in production.
A practical sourcing checklist
Before committing to a peptide order, work through these questions:
Cash flow and financing
- What's the full cash cycle — from first deposit to first revenue? Is it 90 days, 120, or longer?
- Do you have enough working capital to bridge that gap, or do you need a financing facility in place before you commit?
- Have you confirmed the exact deposit amount and the date the balance is due before shipment?
Supplier and lead time
- US or Chinese CMO — have you factored the lead time difference (4–8 weeks vs. 10–14 weeks) into your restock date?
- Does your CMO have current GMP certification and provide batch-specific CoAs from an accredited external lab?
- Can you get a sample or smaller pilot run before committing to your full MOQ?
Cost model
- Have you included freight, import duties, and third-party testing in your unit economics?
- Are there any labeling, compliance, or certification costs specific to your target markets?
Peptides are a high-margin, high-demand category with a real future in wellness trade. The brands that build sustainable positions in it approach sourcing with the same rigour they bring to formulation and marketing — planning the financial mechanics before they're under pressure, not after.